drugset / Trial / NCT03266445

Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use

NCT03266445 ↗

Phase 4 Unknown 76 enrolled Massachusetts General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to determine the effect of continuation of buprenorphine/naloxone in patients with history of Opioid Use Disorder (OUD) scheduled for surgery compared to reduced dose buprenorphine/naloxone prior to surgery on pain scores, opioid consumption, depressive symptoms and severity of substance use dependence- including record of problematic use of any non-prescribed opioids, alcohol and illicit narcotics.

Timeline

Start
2018-10-05
Primary completion
2021-12-31
Completion
2022-02-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator buprenorphine/naloxone Unknown 8 mg —

Indications